Researchers in Prof. James Swartz' laboratory have developed a rapid bioluminescence method for detecting and enumerating circulating tumor cells (CTCs) and other rare cells. This invention utilizes novel nanoparticle reagents which can specifically bind to cells of interest.
Circulating levels of Neuromedin U (NMU) peptide are correlated with insulin resistance and obesity and dynamically regulated to suppress insulin secretion.
Researchers in Prof. Emmanuel Mignot's laboratory developed a mouse monoclonal antibody to the N-terminal end of the hypocretin-1 protein (Hcrt-1, also known as orexin-A).
Researchers in Dr. Michael Cleary's laboratory at Stanford University have developed a highly specific monoclonal antibody for AF5, a proto-oncoprotein associated with pediatric and adult acute leukemia.
Researchers in Prof. Stephen Quake's laboratory have developed a method to measure the entire fetal genome noninvasively using materials from maternal blood.
A team of Stanford researchers has developed an in vitro system for the detection and quantification of basophils. The technology can be used to identify and monitor patients with immune system disorders - such as anaphylaxis, myeloproliferative disorders, or infections.
Stanford scientists in Dr. Liqun Luo's laboratory have developed a patented method for site-directed somatic cell recombination and concurrent labeling of "knock in" cells.
Monoclonal antibody that recognizes MLL, an oncoprotein that is mutated in a broad subset of pediatric and adult leukemias. MLL protein displays histone methyltransferase activity.
Rat monoclonal antibody isotype IgG2a (clone #153) recognizes the HA peptide sequence [YPYDVPDYA] derived from the influenza hemagglutinin protein. The HA peptide can be added to unrelated proteins through recombinant techniques.
12E7 antibody that can be used to diagnose and differentiation of peripheral ectodermal tumors (PNET) and Ewing's sarcomas, as well as in therapeutic applications and bone marrow transplantation.
The 4G7 hybridoma secretes an IgG1 antibody that is specific for normal and malignant B lymphocytes and can be used for the study of B cell differentiation and for the characterization of lymphoid malignancies.
Murine Monoclonal Anitbodies Against Normal Malignant Human T-Cells. (Leu-9)
Lab designation: SBCV9.1, This hybridoma produces a monoclonal antibody IgG2b against normal and malignant human T cells. It appears to be an equivalent of anti-Leu-9.